<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03699878</url>
  </required_header>
  <id_info>
    <org_study_id>4-2018-0773</org_study_id>
    <nct_id>NCT03699878</nct_id>
  </id_info>
  <brief_title>Impact of Perioperative Shedding of the Endothelial Glycocalyx on Short-term Postoperative Complication in Patients Undergoing Robot-assisted Esophagectomy</brief_title>
  <official_title>Impact of Perioperative Shedding of the Endothelial Glycocalyx on Short-term Postoperative Complication in Patients Undergoing Robot-assisted Esophagectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study was to determine whether changes in serum levels of syndecan-1 before
      and after surgery, which is an index related to injury of the endothelial glycocalyx layer,
      are associated with postoperative short-term complications and mortality in patients
      undergoing robotic esophagectomy.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 14, 2018</start_date>
  <completion_date type="Anticipated">December 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>base blood concentration of syndecan-1</measure>
    <time_frame>within 1 hour before surgery</time_frame>
    <description>preoperative baseline serum levels of syndecan-1</description>
  </primary_outcome>
  <primary_outcome>
    <measure>blood concentration of syndecan-1 at the end of the surgery</measure>
    <time_frame>within 5 minutes after the end of surgery (when thd surgical drape is removed)</time_frame>
    <description>blood concentration of syndecan-1 at the end of the surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>blood concentration of syndecan-1 at 24 hours after surgery</measure>
    <time_frame>24 hours after the end of surgery</time_frame>
    <description>blood concentration of syndecan-1 at 24 hours after surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Unanticipated Post-Operative Invasive Procedure (STS GTSD 2.41 #3330)</measure>
    <time_frame>during this 1 day hospital visit.</time_frame>
    <description>Indicate if the patient had an unplanned invasive procedure after surgery. Examples includes return to the operating room for a redo surgical procedure, a percutaneous procedure performed at bedside or in the radiology suite, a tracheostomy, and wound opening at bedside. Exclusions: postoperative toilet bronchoscopy, central venous access, arterial line placement, foley catheter placement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anastomotic leak following esophageal surgery(STS GTSD 2.41 #3350)</measure>
    <time_frame>within 30days after end of surgery</time_frame>
    <description>Indicate if the patient had an anastomotic leak following esophageal surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory Failure(STS GTSD 2.41 #3480)</measure>
    <time_frame>within 30days after end of surgery</time_frame>
    <description>Indicate whether the patient experienced respiratory failure in the postoperative period requiring mechanical ventilation and/or reintubation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>initial ventilatory support greater than 48 hours (STS GTSD 2.41 #3520)</measure>
    <time_frame>within 30days after end of surgery</time_frame>
    <description>Indicate if the patient experienced pneumonia in the postoperative period. Pneumonia is defined as meeting three of five characteristics: fever (&gt; 100.4 F or 38 C), leukocytosis, CXR with infiltrate, positive culture from sputum, or treatment with antibiotics.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pneumonia (STS GTSD 2.41 #3460)</measure>
    <time_frame>within 30days after end of surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>renal failure(STS GTSD 2.41 #3810)</measure>
    <time_frame>within 30days after end of surgery</time_frame>
    <description>Indicate whether the patient had acute renal failure or worsening renal function resulting in any of the following:
New requirement for dialysis post-operatively
Increase in serum creatinine level 3.0 x greater than baseline
serum creatinine level â‰¥4 mg/dL , with an acute rise of at least 0.5 mg/dl</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mortality(Status 30 Days after Surgery, STS GTSD 2.41 #3950)</measure>
    <time_frame>30days post-surgery</time_frame>
    <description>Indicate whether the patient was alive or dead at 30 days post-surgery (whether in the hospital or not).
time frame: 30days post-surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute kidney injury</measure>
    <time_frame>within 48 h after end of surgery</time_frame>
    <description>defined as an absolute increase in serum creatinine level C0.3 mg/dL, a 50% (1.5-fold) increase in serum creatinine level from baseline, or a reduction in urine output (documented oliguria&lt; 0.5 mL/kg/h for 6h)</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Robotic Esophagectomy</condition>
  <arm_group>
    <arm_group_label>patients undergoing robotic esophagectomy</arm_group_label>
    <description>Patients 20 years or older who undergo robotic esophagectomy</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        patients 20 years or older who undergo robotic esophagectomy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        1. patients 20 years or older who undergo robotic esophagectomy

        Exclusion Criteria:

          1. Emergency surgery

          2. If the subject includes a person who can not read the written consent (eg, illiterate,
             foreigner, etc.)

          3. Chronic kidney disease (eGFR &lt;30 mL / min / 1.73 m2)

          4. Pregnant and lactating women
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>So Yeon Kim, MD,PhD.</last_name>
    <phone>82-2-2227-4470</phone>
    <email>KIMSY326@yuhs.ac</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine</name>
      <address>
        <city>Seoul</city>
        <zip>03722</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>So Yeon Kim, MD,PhD.</last_name>
      <phone>82-2-2227-4470</phone>
      <email>KIMSY326@yuhs.ac</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>October 5, 2018</study_first_submitted>
  <study_first_submitted_qc>October 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 9, 2018</study_first_posted>
  <last_update_submitted>May 7, 2019</last_update_submitted>
  <last_update_submitted_qc>May 7, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 9, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

